Key result
A deep learning framework for automated closed-loop neuromodulation correctly identified 88.26% of trials for intervention application, demonstrating feasibility for multimodal stimulation.
Why the study?
Conventional closed-loop stimulation approaches can contain biased biomarker detection and stimulation-type application.
A novel deep learning framework for closed-loop neuromodulation demonstrated high accuracy in identifying opportune times for stimulation based on physiological and neuronal data.
Demonstrates feasibility of AI-driven neuromodulation; leaves open clinical efficacy and safety in prospective trials.
Closed-loop neuromodulation measures dynamic neural or physiological activity to optimize interventions for clinical and nonclinical behavioral, cognitive, wellness, attentional, or general task performance enhancement. Conventional closed-loop stimulation approaches can contain biased biomarker detection (decoders and error-based triggering) and stimulation-type application. We present and verify a novel deep learning framework for designing and deploying flexible, data-driven, automated closed-loop neuromodulation that is scalable using diverse datasets, agnostic to stimulation technology (supporting multi-modal stimulation: tACS, tDCS, tFUS, TMS), and without the need for personalized ground-truth performance data. Our approach is based on identified periods of responsiveness - detected states that result in a change in performance when stimulation is applied compared to no stimulation. To demonstrate our framework, we acquire, analyze, and apply a data-driven approach to our open sourced GX dataset, which includes concurrent physiological (ECG, EOG) and neuronal (EEG) measures, paired with continuous vigilance/attention-fatigue tracking, and High-Definition transcranial electrical stimulation (HD-tES). Our framework's decision process for intervention application identified 88.26% of trials as correct applications, showed potential improvement with varying stimulation types, or missed opportunities to stimulate, whereas 11.25% of trials were predicted to stimulate at inopportune times. With emerging datasets and stimulation technologies, our unifying and integrative framework; leveraging deep learning (Convolutional Neural Networks - CNNs); demonstrates the adaptability and feasibility of automated multimodal neuromodulation for both clinical and nonclinical applications.
No takes yet. Share an insight, caveat, or question.
Gebodh et al. (2023) studied this question. Deep learning framework for closed-loop neuromodulation was evaluated on Correct application of intervention. A deep learning framework for automated closed-loop neuromodulation correctly identified 88.26% of trials for intervention application, demonstrating feasibility for multimodal stimulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: